Goserelin and preservation of ovarian function among breast cancer patients treated with adjuvant cytotoxic chemotherapy: results from a randomised trial.

被引：0
|
作者：
Sverrisdottir, A.
Nystedt, M.
Fornander, T.
机构：
[1] Univ Hosp, Karolinska Inst, Stockholm, Sweden
[2] Landspitali Univ Hosp, Reykjavik, Iceland
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2006年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：S110 / S110
页数：1
相关论文
共 50 条
  • [1] Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial
    A. Sverrisdottir
    M. Nystedt
    H. Johansson
    T. Fornander
    Breast Cancer Research and Treatment, 2009, 117
  • [2] Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial
    Sverrisdottir, A.
    Nystedt, M.
    Johansson, H.
    Fornander, T.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 117 (03) : 561 - 567
  • [3] The OPTION trial of adjuvant ovarian protection by goserelin in adjuvant chemotherapy for early breast cancer
    Leonard, R. C.
    Adamson, D.
    Anderson, R.
    Ballinger, R.
    Bertelli, G.
    Coleman, R. E.
    Fallowfield, L.
    McLinden, M.
    Mansi, J.
    Thomas, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Preservation of ovarian function with goserelin in young breast cancer patients: Does it hamper the effect of neoadjuvant chemotherapy?
    Wang, S. Y.
    Wang, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S52 - S52
  • [5] Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy
    Moore, Halle C. F.
    Unger, Joseph M.
    Phillips, Kelly-Anne
    Boyle, Frances
    Hitre, Erika
    Porter, David
    Francis, Prudence A.
    Goldstein, Lori J.
    Gomez, Henry L.
    Vallejos, Carlos S.
    Partridge, Ann H.
    Dakhil, Shaker R.
    Garcia, Agustin A.
    Gralow, Julie
    Lombard, Janine M.
    Forbes, John F.
    Martino, Silvana
    Barlow, William E.
    Fabian, Carol J.
    Minasian, Lori
    Meyskens, Frank L., Jr.
    Gelber, Richard D.
    Hortobagyi, Gabriel N.
    Albain, Kathy S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (10): : 923 - 932
  • [6] Goserelin for Ovarian Protection During Breast-Cancer Adjuvant Chemotherapy
    Moore, Halle C. F.
    Unger, Joseph M.
    Phillips, Kelly-Anne
    Boyle, Frances
    Hitre, Erika
    Porter, David
    Francis, Prudence A.
    Goldstein, Lori J.
    Gomez, Henry L.
    Vallejos, Carlos S.
    Partridge, Ann H.
    Dakhil, Shaker R.
    Garcia, Agustin A.
    Gralow, Julie
    Lombard, Janine M.
    Forbe, John F.
    Martino, Silvana
    Barlow, William E.
    Fabian, Carol J.
    Minasian, Lori
    Meyskens, Frank L., Jr.
    Gelber, Richard D.
    Hortobagyi, Gabriel N.
    Albain, Kathy S.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2015, 70 (06) : 392 - +
  • [7] Temporary Ovarian Suppression With Goserelin and Ovarian Function Protection in Patients With Breast Cancer Undergoing Chemotherapy
    Del Mastro, Lucia
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (24) : 3339 - 3340
  • [8] Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer
    Bines, J
    Oleske, DM
    Cobleigh, MA
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (05) : 1718 - 1729
  • [9] Randomized trial of adjuvant ovarian suppression in 926 premenopausal patients with early breast cancer treated with adjuvant chemotherapy
    Arriagada, R
    Lê, MG
    Spielmann, M
    Mauriac, L
    Bonneterre, J
    Namer, M
    Delozier, T
    Hill, C
    Tursz, T
    ANNALS OF ONCOLOGY, 2005, 16 (03) : 389 - 396
  • [10] Ovarian function protection with goserelin during adjuvant chemotherapy in pre-menopausal women with early breast cancer
    Urruticoechea, A
    Walsh, G
    Rigg, A
    Dousett, M
    Smith, IE
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S229 - S230
12345